URINARY UROMODULIN IS POSITIVELY ASSOCIATED WITH TOTAL CARDIOVASCULAR RISK IN MIDDLE-AGED NON-TREATED SUBJECTS WITH HIGH-NORMAL BLOOD PRESSURE